Reaction

Diabetic Retinopathy reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 3,355 reports · 90 co-occurring drugs

As of the last recalculation, Diabetic Retinopathy appears in 3,355 FAERS reports alongside 90 co-occurring drug terms. The strongest observed disproportionality signal is INSULIN HUMAN (PRR 57.2).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Insulin Human	331	57.2	57.7
Human Insulin	80	40.7	40.9
Insulin Glulisine	64	39.8	40.0
Insulin Lispro	646	35.7	35.8
Insulin Aspart	320	33.1	33.3
Insulin Degludec	116	31.7	31.9
Insulin Glargine	823	27.1	27.2
Ranibizumab	110	26.5	26.7
Faricimab	32	24.7	24.8
Insulin Glargine-Yfgn	79	22.9	23.0
Insulin	166	19.4	19.4
Glyburide	62	16.2	16.2
Ziprasidone Mesylate	34	14.9	15.0
Oral Semaglutide	160	14.1	14.2
Pioglitazone	93	13.7	13.7
Olanzapine Pamoate	84	13.0	13.1
Ziprasidone	35	12.4	12.5
Gemfibrozil	27	11.1	11.1
Aflibercept	51	10.3	10.3
Liraglutide	77	9.9	9.9
Enalapril Maleate	39	9.9	9.9
Cefazolin Sodium	19	9.8	9.8
Glipizide	84	8.8	8.8
Glimepiride	54	8.7	8.7
Dulaglutide	119	8.6	8.6
Cefazolin	12	8.2	8.2
Metformin Hcl	70	8.0	8.0
Diphenhydramine Hcl	14	7.8	7.8
Metformin	389	7.5	7.5
Amlodipine Besylate And Benazepril Hydrochloride	11	7.4	7.4
Metformin Er 500 Mg	327	7.4	7.4
Metformin Er 750 Mg	327	7.4	7.4
Metformin Hydrochloride	66	7.0	7.0
Enalapril	62	7.0	7.0
Metformin Hydrochloride Tablets	63	6.9	6.9
Metformin Hydrochloride Extended-Release Tablets	63	6.9	6.9
Metformin Hydrochloride Tablet	63	6.9	6.9
Sitagliptin	78	6.8	6.9
Exenatide	52	6.2	6.2
Empagliflozin	66	6.2	6.2
Cephalexin	21	6.1	6.1
Ezetimibe And Simvastatin	14	5.7	5.7
Valsartan	94	5.7	5.7
Divalproex Sodium	42	5.7	5.7
Quetiapine	168	5.6	5.6
Vitamin E	28	5.6	5.6
Nitroglycerin	47	5.5	5.5
Lithium Carbonate	15	5.5	5.5
Dapagliflozin	27	5.4	5.4
Niacin	10	5.4	5.4
Clonidine	43	5.3	5.3
Olanzapine	87	5.1	5.1
Valsartan And Hydrochlorothiazide	11	5.0	5.0
Brinzolamide	7	5.0	5.0
Sitagliptin And Metformin Hydrochloride	17	4.9	4.9
Brimonidine Tartrate	14	4.9	4.9
Prednisolone Acetate	8	4.8	4.8
Epoetin Alfa	9	4.7	4.7
Clotrimazole	9	4.6	4.6
Isosorbide Dinitrate	14	4.5	4.5
Valsartan Oral	38	4.4	4.4
Trazodone Hydrochloride	11	4.4	4.4
Nifedipine	33	4.4	4.4
Doxazosin Mesylate	25	4.3	4.3
Pitavastatin Calcium	7	4.3	4.3
Atorvastatin Calcium	161	4.2	4.2
Bosutinib	6	4.1	4.2
Simvastatin	159	4.1	4.1
Valganciclovir Hydrochloride Powder,	8	4.1	4.1
Doxazosin	18	4.0	4.0
Erythropoietin	13	3.9	3.9
Dorzolamide Hydrochloride And Timolol Maleate	5	3.9	3.9
Lovastatin	16	3.9	3.9
Losartan Potassium	48	3.8	3.8
Lisinopril	179	3.8	3.8
Linagliptin	11	3.8	3.8
Bimatoprost	16	3.5	3.5
Amlodipine Besylate And Valsartan	6	3.4	3.4
Bevacizumab	65	3.3	3.3
Risperidone	69	3.3	3.3
Paricalcitol	7	3.1	3.1
Latanoprost	24	3.0	3.0
Imatinib Mesylate	13	2.9	2.9
Darbepoetin Alfa	24	2.8	2.8
Tirzepatide	70	2.7	2.7
Fingolimod Hcl	30	2.2	2.2
Canagliflozin	9	1.9	1.9
Methoxy Polyethylene Glycol-Epoetin Beta	3	1.7	1.7
Minoxidil Foam 5% (Womens)	6	1.1	1.1
Minoxidil	6	0.8	0.8

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.